Brain Stimulation Effects on Cognitive Task Performance

NCT ID: NCT05556655

Last Updated: 2025-02-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-20

Study Completion Date

2027-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine optimal task design parameters for the measurement of transcranial magnetic stimulation (TMS) effects on cognition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Transcranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation that relies on rapidly changing magnetic fields to influence neuronal firing rates. TMS can be used to temporarily inhibit or enhance the firing of populations of neurons located in the cerebral cortex. TMS-induced cortical inhibition versus enhancement is increasingly being used as a tool for exploring brain-behavior relationships and for improving cognitive functioning in people experiencing cognitive deficits due to neuropsychiatric illness (e.g., dementia and schizophrenia). However, important and unresolved methodological issues in this field concern the optimal design of cognitive tasks for TMS stimulation protocols. The purpose of this study is to determine optimal design protocols for online TMS studies of cognitive processes involved in attention, learning, and memory. Research participants will complete cognitive tasks while active versus sham (i.e., non-stimulating) TMS is applied to the brain. A factorial design will be used to determine the combination of task and TMS parameters (i.e., device settings) that produce the most robust and reliable behavioral effects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognitive Function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Mechanistic study of impact of transcranial magnetic stimulation (TMS) on cognitive function.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants
Participants are blinded to TMS therapy, sham control

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active TMS

Repetitive TMS for the brain

Group Type EXPERIMENTAL

Transcranial Magnetic Stimulation

Intervention Type DEVICE

Transcranial Magnetic Stimulation (TMS) is a noninvasive method for stimulating neurons (axons not cell bodies) in the brain.

Sham TMS

Scalp stimulation that does not affect the brain.

Group Type PLACEBO_COMPARATOR

Transcranial Magnetic Stimulation

Intervention Type DEVICE

Transcranial Magnetic Stimulation (TMS) is a noninvasive method for stimulating neurons (axons not cell bodies) in the brain.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcranial Magnetic Stimulation

Transcranial Magnetic Stimulation (TMS) is a noninvasive method for stimulating neurons (axons not cell bodies) in the brain.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Right-handed
* Fluent in English

Exclusion Criteria

* History of seizures or epilepsy
* Family history of epilepsy
* Significant medical or neurological diagnoses
* History of common headache or migraine
* History of common or recent syncope
* History of moderate/severe, multiple mild, or past 12 months head injury
* History of psychiatric, psychological, or neurodevelopmental disorder
* History of alcohol or recreational drug abuse or dependence
* Current visual or hearing difficulties that interfere with cognitive testing
* History of cochlear implants
* Current pregnancy
* History of metal in the head or neck (except braces and fillings)
* Current non-removable piercings in the neck or head
* History of implanted neurostimulator
* History of cardiac pacemaker or intracardiac lines
* History of medication infusion device
* Current use of medications that increase the excitability of the brain
* History of problems with TMS or MRI procedures
* History of EEG for suspected epilepsy
* Alcohol or recreational drug use in the 48 hours prior to TMS
* Inadequate sleep in the 48 hours prior to TMS
* Headache or feeling faint in the 24 hours prior to TMS.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Colorado State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Colorado State University Department of Psychology

Fort Collins, Colorado, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Michael Thomas, PhD

Role: CONTACT

(970) 491-6820

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Michael L Thomas, PhD

Role: primary

970-491-6820

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3502

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Characterizing the Scalp Tolerability of TMS
NCT06354686 ACTIVE_NOT_RECRUITING NA
Effect of TMS on PTSD Biomarkers
NCT04563078 COMPLETED NA
Modeling TMS-induced Cortical Network Activity
NCT05288959 NOT_YET_RECRUITING NA
rTMS in First Episode Psychosis
NCT02131129 COMPLETED NA
Effects of Alpha tACS
NCT03135639 COMPLETED NA